Pulmonary hypertension: a contraindication to the use of {beta}-adrenoceptor blocking agents.

@article{Peacock2010PulmonaryHA,
  title={Pulmonary hypertension: a contraindication to the use of \{beta\}-adrenoceptor blocking agents.},
  author={A J Peacock and Kannan Ross},
  journal={Thorax},
  year={2010},
  volume={65 5},
  pages={
          454-5
        }
}
Supraventricular tachycardia (SVT) is a rare but important complication of pulmonary arterial hypertension. beta-Adrenoceptor blocking agents are commonly used to treat SVT, but they are potentially dangerous in the context of pulmonary arterial hypertension. Their negative inotropic and chronotropic effects are poorly tolerated in this condition, where cardiac reserve is compromised by a reduced and fixed stroke volume, and their administration can result in significant cardiorespiratory… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 31 CITATIONS

Principles and Practice of Anesthesia for Thoracic Surgery

VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Treatment of group I pulmonary arterial hypertension with carvedilol is safe.

VIEW 11 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

Portal hypertension and its complications.

ERS Task Force Pulmonary - Hepatic Vascular Disorders Scientific Committee . Pulmonary - hepatic vascular disorders

  • R Rodriguez-Roisin, MJ Krowka, P Herve
  • Eur Respir J
  • 2004

Shock syndrome after acebutolol.